Summit Biosciences Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Employees
  • 97
Employees
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 4

Summit Biosciences General Information

Description

Provider of specialized pharmaceutical products intended to focus on developing, manufacturing, and commercializing generic and innovative nasal spray medicines. The company's products offer commercial production of unit-dose, nasal spray products with development and production of pre-filled, disposable, intranasal spray products, enabling clients to address and meet important needs for the management of chronic and acute care conditions.

Contact Information

Website
www.summitbiosciences.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • UK Coldstream Research Campus
  • 1513 Bull Lea Road
  • Lexington, KY 40511
  • United States
+1 (859) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Summit Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 18-Nov-2016 00000 Completed Generating Revenue
3. Debt - General 10-Sep-2014 00000 Completed Generating Revenue
2. Early Stage VC 04-May-2012 $350K $350K Completed Generating Revenue
1. Grant 08-Nov-2010 $250K Completed Generating Revenue
To view Summit Biosciences’s complete valuation and funding history, request access »

Summit Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of specialized pharmaceutical products intended to focus on developing, manufacturing, and commercializing gene
Drug Discovery
Lexington, KY
97 As of 2021
00000
000000000000 00000

00000 00

inim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis
000000000000000
Chandler, AZ
00 As of 0000
000.00
0000000000.

000000 0

liqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea comm
0000 000000000
Herzliya, Israel
0 As of 0000
000.00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Summit Biosciences Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Insys Therapeutics Corporation Chandler, AZ 00 000.00 0000000000.
000000 00000000000 Venture Capital-Backed Herzliya, Israel 0 000.00 00000000000 000.00
000000000 000 Corporation Highlands Ranch, CO 00
00000 000000000000 Venture Capital-Backed San Diego, CA 00 0000 000000 - 000 0000
To view Summit Biosciences’s complete competitors history, request access »

Summit Biosciences Executive Team (5)

Name Title Board Seat Contact Info
Gregory Plucinski Chief Operating Officer & President
Sonia Egbert Chief Accounting Officer
Ted Marcuccio Chief Business Officer
Edwin Cohen Founder, Chief Executive Officer & Chairman of the Board
To view Summit Biosciences’s complete executive team members history, request access »

Summit Biosciences Board Members (6)

Name Representing Role Since
Edwin Cohen Summit Biosciences Founder, Chief Executive Officer & Chairman of the Board 000 0000
Patrick Lowe Summit Biosciences Board Member 000 0000
R. Charles Moyer Ph.D Self Board Member 000 0000
Richard Cohen Self Board Member 000 0000
Robert Saunders Ph.D Self Board Observer 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Summit Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Summit Biosciences Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Kentucky Innovation Network Accelerator/Incubator 000 0000 000000 0
Startups@KSTC Venture Capital Minority 000 0000 000000 0
Yearling Management Venture Capital Minority 000 0000 000000 0
Kentucky Cabinet for Economic Development Business Development Company 000 0000 000000 0
To view Summit Biosciences’s complete investors history, request access »

Ready to get started?

Request a free trial